science
Unapproved gene therapy for boosting longevity is set to go on sale
Why this matters: new research or scientific developments with potential real-world impact.
A gene therapy that instructs cells to produce more of an anti-ageing protein called klotho is about to be offered by a US company at overseas clinics to bypass FDA rules
Read full story on New Scientist → More top storiesAlso covered by
Aggregated and edited by the Scoop newsroom. We surface news from New Scientist alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop